as on March 3, 2026 at 7:59 am IST
Day's Low
6.07%
Downside
52 Week's Low
52 Week's High
34.11%
Downside
147.66%
Upside
Check Vivosim Labs Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.7M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
1.23
Industry PE ratio
0PEG Ratio
0Return On Equity TTM
-51.07%
Track how Vivosim Labs Inc P/E has moved over time to understand its valuation trends.
Vivosim Labs Inc in the last 5 years
Lowest (-12.46x)
September 30, 2025
Industry (0.00x)
March 3, 2026
Today (1.23x)
March 3, 2026
Highest (2.25x)
December 31, 2025
Today’s Price to Earnings Ratio: 1.23x
Compare market cap, revenue, PE, and other key metrics of Vivosim Labs Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $5.7M | NA | 1.23 | 0.00% | |
| BUY | $126.2B | 133.18% | 32.47 | 32.94% | |
| BUY | $44.2B | 125.24% | 142.88 | 8.45% | |
| NA | $35.1B | NA | 621.55 | 5.37% | |
| BUY | $82.6B | 77.02% | 18.83 | 31.41% |
Search interest for Vivosim Labs Inc Stock has increased by 1062% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1062% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, VIVS stock has moved up by 13.4%
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 152.1%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.5% return, outperforming this stock by 107.3%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -2.54M → -2.69M (in $), with an average decrease of 5.7% per quarter
Revenue Fall
![]()
Revenue is down for the last 4 quarters, 51.0K → 26.0K (in $), with an average decrease of 19.6% per quarter
| Organisation | Vivosim Labs Inc |
| Headquarters | 11555 Sorrento Valley Road, San Diego, CA, United States, 92121 |
| CEO | Mr. Keith E. Murphy |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Curtis M. Tyree Ph.D. | Senior Vice President of Strategy & Business Development |
Mr. Tony Lialin | Chief Commercial Officer |
Mr. Keith E. Murphy | Executive Chairman & Corporate Secretary |
Mr. Norman Staskey | President, CFO & Principal Financial Officer |
Dr. Amar A. Sethi M.D., Ph.D. | Chief Scientific Officer |
Vivosim Labs Inc share price today is $2.14 as on at the close of the market. Vivosim Labs Inc share today touched a day high of $2.14 and a low of $2.01.
Vivosim Labs Inc share touched a 52 week high of $5.3 on and a 52 week low of $1.41 on . Vivosim Labs Inc stock price today i.e. is closed at $2.14,which is 59.62% down from its 52 week high and 51.77% up from its 52 week low.
Vivosim Labs Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Vivosim Labs Inc (VIVS) shares with as little as ₹91.474 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹914.74 in Vivosim Labs Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Vivosim Labs Inc share’s latest price of $2.14 as on March 3, 2026 at 2:29 am IST, you will get 4.6729 shares of Vivosim Labs Inc. Learn more about
fractional shares .